The AstraZeneca share price could be considerably undervalued according to analysts. Dr James Fox takes a closer look at the ...

Can the integration of its big acquisition from 2022 finally lead Rentokil Initial to outperform the FTSE 100 next year? Or ...

The 90% profit distribution rule applied to REITs makes them an attractive option for dividend investors. Here are two of my ...

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less ...

Analysts are expecting sales growth of around 50% for Nvidia over the next 12 months – so why is Stephen Wright pessimistic ...

Harvey Jones thought the Glencore share price was a screaming buy 18 months ago, but it hasn't done as well as he hoped. Can ...

With US wages outpacing inflation and shares at an average price-to-sales ratio, why do analyst forecasts for the Tesla share ...

The Barclays share price has seen a strong resurgence in 2024 after years out in the cold. Can 2025 carry on the upwards ...

This ultra-high-yielding FTSE 250 income stock’s very cheap trading at less than 10 times earnings. Harvey Jones wonders if ...

The boohoo share price is finally showing a bit of resilience as we reach the end of 2024. But there's still a lot to do in ...

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less ...

There are simple reasons why the Lloyds share price should recover in 2025 and beyond. Dr James Fox highlights how the bank’s ...